Home » Topics » Regulatory » Patents

Patents
RSS

Takeda claims glucokinase activators for the treatment of diabetes

Dec. 21, 2009

Novartis discovers novel compounds for the treatment of parasitic infections

Dec. 21, 2009

Incyte identifies JAK inhibitors for cancer therapy

Dec. 18, 2009

Orexin receptor antagonists in development at GSK for the treatment of sleep disorders

Dec. 18, 2009

Solvay presents novel CB1 receptor antagonists for obesity therapy

Dec. 18, 2009

Institute for OneWorld Health claims CFTR inhibitors for the treatment of diarrhea

Dec. 18, 2009

Vitae Pharmaceuticals describes novel antidiabetic compounds

Dec. 18, 2009

Columbia University identifies VMAT2 ligands for the treatment of diabetes

Dec. 17, 2009

Daiichi Sankyo presents novel antibacterial compounds

Dec. 17, 2009

BMS identifies novel nAChR agonists

Dec. 17, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...